| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1081 | 2019 |
| Muscle wasting is associated with mortality in patients with cirrhosis AJ Montano–Loza, J Meza–Junco, CMM Prado, JR Lieffers, VE Baracos, ... Clinical Gastroenterology and Hepatology 10 (2), 166-173. e1, 2012 | 913 | 2012 |
| Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value P Tandon, M Ney, I Irwin, MM Ma, L Gramlich, VG Bain, N Esfandiari, ... Liver Transplantation 18 (10), 1209-1216, 2012 | 628 | 2012 |
| Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis AJ Montano‐Loza, P Angulo, J Meza‐Junco, CMM Prado, MB Sawyer, ... Journal of cachexia, sarcopenia and muscle 7 (2), 126-135, 2016 | 506 | 2016 |
| A multicenter study to define sarcopenia in patients with end‐stage liver disease EJ Carey, JC Lai, CW Wang, S Dasarathy, I Lobach, AJ Montano‐Loza, ... Liver Transplantation 23 (5), 625-633, 2017 | 438 | 2017 |
| Autoimmune hepatitis G Mieli-Vergani, D Vergani, AJ Czaja, MP Manns, EL Krawitt, JM Vierling, ... Nature Reviews Disease Primers 4 (1), 1-21, 2018 | 420 | 2018 |
| Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis AJ Montano-Loza, A Duarte-Rojo, J Meza-Junco, VE Baracos, MB Sawyer, ... Clinical and translational gastroenterology 6 (7), e102, 2015 | 364 | 2015 |
| Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation AJ Montano‐Loza, J Meza‐Junco, VE Baracos, CMM Prado, M Ma, ... Liver Transplantation 20 (6), 640-648, 2014 | 359 | 2014 |
| Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma J Meza-Junco, AJ Montano-Loza, VE Baracos, CMM Prado, VG Bain, ... Journal of clinical gastroenterology 47 (10), 861-870, 2013 | 273 | 2013 |
| Clinical relevance of sarcopenia in patients with cirrhosis AJ Montano-Loza World Journal of Gastroenterology: WJG 20 (25), 8061, 2014 | 272 | 2014 |
| Perspective: improving vitamin D status in the management of COVID-19 M Ebadi, AJ Montano-Loza European journal of clinical nutrition 74 (6), 856-859, 2020 | 261 | 2020 |
| Sarcopenia in cirrhosis: from pathogenesis to interventions M Ebadi, RA Bhanji, VC Mazurak, AJ Montano-Loza Journal of gastroenterology 54 (10), 845-859, 2019 | 247 | 2019 |
| Sarcopenia and frailty in decompensated cirrhosis P Tandon, AJ Montano-Loza, JC Lai, S Dasarathy, M Merli Journal of hepatology 75, S147-S162, 2021 | 229 | 2021 |
| A North American expert opinion statement on sarcopenia in liver transplantation EJ Carey, JC Lai, C Sonnenday, EB Tapper, P Tandon, A Duarte‐Rojo, ... Hepatology 70 (5), 1816-1829, 2019 | 222 | 2019 |
| Exercise and physical activity for patients with end‐stage liver disease: improving functional status and sarcopenia while on the transplant waiting list A Duarte‐Rojo, A Ruiz‐Margáin, AJ Montaño‐Loza, ... Liver Transplantation 24 (1), 122-139, 2018 | 222 | 2018 |
| Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice JC Lai, CJ Sonnenday, EB Tapper, A Duarte-Rojo, MA Dunn, W Bernal, ... American journal of transplantation 19 (7), 1896-1906, 2019 | 214 | 2019 |
| Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis RA Bhanji, C Moctezuma-Velazquez, A Duarte-Rojo, M Ebadi, S Ghosh, ... Hepatology international 12, 377-386, 2018 | 201 | 2018 |
| Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse AJ Montano-Loza, HA Carpenter, AJ Czaja Official journal of the American College of Gastroenterology| ACG 102 (5 …, 2007 | 200 | 2007 |
| Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end‐stage liver disease AJ Montano‐Loza, HA Carpenter, AJ Czaja Hepatology 46 (4), 1138-1145, 2007 | 179 | 2007 |
| The Association of Helicobacter pylori Infection and Nonsteroidal Anti‐Inflammatory Drugs in Peptic Ulcer Disease JC Zapata-Colindres, S Zepeda-Gómez, A Montaño-Loza, ... Canadian Journal of Gastroenterology and Hepatology 20 (4), 277-280, 2006 | 159 | 2006 |
